Endoscopic equipment has been a revolutionary work in achievement of surgical procedures with minimal invasion.
Apart from use in various types of surgeries, endoscopy equipments are now also being used for non-surgical applications in the form of internal diagnostic tool and even for anatomical observations.
Due to these multiple uses, its market continues to grow worldwide. Meanwhile, the competitive landscape of the European gastrointestinal endoscopy device market will continue to favor large companies with wide product portfolios that can bundle products to win contracts with budget-conscious hospitals.
The endoscopy market worldwide was USD23.3 billion in 2010 and has been projected to reach nearly USD24.8 billion in 2011.
This is further anticipated to increase to USD33.7 billion by 2016 at a compound annual growth rate (CAGR) of 6.4 percent.
Laparoscopy accounts for more than 26 percent of the total market and is expected to reach USD6.8 billion by end of 2011 and to increase up to USD10.6 billion by 2016 at a compound annual growth rate (CAGR) of 9.2 percent, according to a report published by BCC Research.
Besides, endoscopy of the GI track for tumors, adhesions, diverticulitis, etc. is projected to experience an increase from USD3.7 billion in 2011 to more than USD4.9 billion in 2016, a CAGR of 5.7 percent.
Furthermore, the new advances in endoscopy differ in the extent of innovation; some procedures like narrow band imaging represent incremental innovations in visualization, whereas other techniques such as NOTES and capsule endoscopy represent disruptive innovations that offer significant advantages over conventional endoscopic techniques.
Medical technology market intelligence
The global authority on medical technology market intelligence, increases in colorectal cancer (CRC) screening will drive sales in the European gastrointestinal endoscopy market, helping this market reach a value of USD1 billion by 2016.
While many market segments will grow at a relatively slow annual rate, GI stents will show notable growth through 2016, according to Millennium Research Group (MRG).
With greater CRC screening being promoted and implemented across Europe, there is increased awareness of this cancer and how it can be detected.
Of particular importance is a new flexible sigmoidoscopy screening program planned for rollout in the United Kingdom, which will provide free screenings to susceptible populations.
Screening leads to a greater number of polyps discovered and an increase in CRC diagnoses, driving the number of gastrointestinal endoscopy procedures.
This will particularly boost the sales of polypectomy snares, biopsy forceps, hemostasis devices and GI videoscopes.
With a compound annual growth rate of over 13 percent, the duodenal/colonic stents will be one of the fastest growing segments in the European gastrointestinal endoscopy device market.
Technological advances in delivery systems, as well as increasing clinical evidence, have made physicians more confident with placing stents instead of pursuing other methods for alleviating strictures.
This will be particularly significant with duodenal/colonic stents, which show significant benefits over open surgery, such as reduced procedure times and quicker patient recovery. Major competitors include Cook Medical, Group DANONE, PENTAX Medical, Nestl and Kimberly-Clark.
Honchos of the market
New research towards development of technologically advanced endoscopic equipments in the US and European countries have resulted in the ever growing use and a steady market growth of endoscopy products in these regions.
Furthermore, the emerging countries like India and China are also catching up on growing use of endoscopic procedures with higher population lending support to their increased usage.
The global endoscopy market is expected to grow at a CAGR of approximately 13.2 percent for the period spanning 2011 to 2014, according to a report by Koncept Analytics.
Intense efforts to provide better medical services have increased the average human life span and aging population at global level is growing.
More surgical interventions are required for treatment of medical problems of the elderly people and minimally invasive surgery is being universally resorted to by the medical practitioners as the most effective recourse.
The market for endoscopy products is highly competitive with several players operating in the market both at a global and regional level.
Technological, price, and service diversities are the key factors responsible for driving competition in the market.
The leading players include Olympus, Johnson & Johnson, Boston Scientific Corporation, Covidien, Stryker, and Karl Storz, among others.